Eversheds in largest pharmaceutical patent infringement award in Spanish history
Eversheds’ Madrid office has successfully represented pharmaceutical company MSD Spain in a landmark patent dispute, setting a new precedent for patent infringement cases.
The Madrid Commercial Court ordered generic drug companies Chemo Iberica and Quimica Sintetica to pay MSD Spain damages of €20m (£16m) for infringement of the Losartan patent. Losartan is commercially known as the hypertension medication Cozaar.
This ground-breaking decision represents the largest pharmaceutical patent infringement award in Spanish judicial history.
The Eversheds Nicea team, led by partners Kiko Carrión and José Mariano Cruz, acted for MSD Spain.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
Terminating long-term distribution agreements; the court’s approach to injunctions to prevent termination
The termination of a long-term distributor or licensing agreement is a serious step for any distributer or supplier.
Trade unions are increasingly using a relatively unknown TULRCA provision in negotiations with employers over changes to collectively agreed terms and conditions.
Analysis from The Lawyer
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?